Evaluation of Continuous Positive Airway Pressure for Tumor Motion Management in Radiotherapy
Evaluation of CPAP (Continuous Positive Airway Pressure) in the Planning of Radiation Treatments for Lung, Upper Abdomen and Left Breast Cancers
1 other identifier
interventional
30
1 country
1
Brief Summary
This is a clinical study on patients to compare the effects of CPAP on lung volume diaphragm motion, heart position and tumor motion compared to free breathing. Only patients with significant tumor motion of greater than 1 cm amplitude or unfavorable chest wall geometry (heart close to chest wall) identified on standard imaging and simulation will be candidates for the study. Patients will be re- simulated and planned for radiation treatments with CPAP. The radiation plans generated with and without CPAP will be compared to evaluate the impact of CPAP on tumor motion and dose delivered to adjacent critical structures such as the heart and lung.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Dec 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 10, 2014
CompletedFirst Posted
Study publicly available on registry
December 24, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedDecember 24, 2014
December 1, 2014
2 years
December 10, 2014
December 18, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction in amplitude of tumor motion
Measurement of the Internal Target Volume in cc
2 months
Secondary Outcomes (1)
Reduction of radiation dose to critical organs
2 months
Other Outcomes (1)
Tolerability of CPAP
immediate
Study Arms (3)
Lung tumors
EXPERIMENTALPatients with \> 1 cm tumor motion simulated using 4DCT with and without CPAP
Left sided Breast cancer
EXPERIMENTALPatients with heart abutting chest wall will be simulated using 4DCT with and without CPAP
Abdominal tumors
EXPERIMENTALPatient with liver metastases for SBRT or pancreatic tumors will be simulated using 4DCT with and without CPAP
Interventions
CT simulation with and without CPAP
Eligibility Criteria
You may qualify if:
- Lung tumors and nodules with tumor motion greater than 1 cm on standard imaging
- Left sided breast tumors with unfavorable anatomy, viz heart abutting chest wall
- Upper abdominal tumors: Liver and Pancreas with tumor motion greater than 1 cm. (n=10)
You may not qualify if:
- Under 18 years old
- Inability to sign informed consent
- Pregnancy,
- Mental Illness,
- Not legally competent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sheba_Medical_Center
Tel Litwinsky, 5262160, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zvi Symon, MD
Sheba Medical Center
- PRINCIPAL INVESTIGATOR
Jeffrey Goldstein, MD
Sheba Medical Center
- PRINCIPAL INVESTIGATOR
Yaacov R Lawrence, MD
Sheba Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chairman Radiation Oncology
Study Record Dates
First Submitted
December 10, 2014
First Posted
December 24, 2014
Study Start
December 1, 2013
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
December 24, 2014
Record last verified: 2014-12